Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
HE ›
HESPERCO
Trademark search for:
HESPERCO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-11-10 — Application filed
2020-11-13 — Application filed
2021-01-10 — Application filed
2021-04-19 — Assigned to examiner
2021-04-27 — Final disposition recorded
2021-04-27 — Final disposition recorded
2021-04-27 — Final disposition recorded
2021-10-08 — Office action issued
2021-10-14 — Assigned to lie
2021-10-15 — Suspension letter written
2021-10-15 — Letter of suspension e-mailed
2021-10-15 — Notification of letter of suspension e-mailed
2021-10-15 — Teas/email correspondence entered
2021-10-15 — Correspondence received in law office
2022-04-18 — Suspension inquiry written
2022-04-18 — Inquiry to suspension e-mailed
2022-04-18 — Notification of inquiry as to suspension e-mailed
2022-04-19 — Teas response to suspension inquiry received
2022-04-20 — Suspension letter written
2022-04-20 — Letter of suspension e-mailed
2022-04-20 — Notification of letter of suspension e-mailed
2022-04-20 — Teas/email correspondence entered
2022-04-20 — Correspondence received in law office
2022-10-18 — Suspension inquiry written
2022-10-18 — Inquiry to suspension e-mailed
2022-10-18 — Notification of inquiry as to suspension e-mailed
2022-11-30 — Attorney/dom.rep.revoked and/or appointed
2022-11-30 — Teas change of correspondence received
2022-11-30 — Teas revoke/app/change addr of atty/dom rep received
2022-11-30 — Teas withdrawal of attorney received-firm retains
2023-05-02 — Application abandoned
2023-05-02 — Application abandoned
2023-05-02 — Application abandoned
2023-05-02 — Final status recorded
Owner Information
Pharmaceutique Ingenew Inc.
Montreal, Quebec CA
Correspondent
Sarah Anne Keefe WOMBLE BOND DICKINSON (US) LLP 470 Atlantic Avenue, Suite 600 Boston, MA 02210-2228 UNITED STATES
Filing Details
Filing Date:
2020-11-10
Status Date:
2023-05-02
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.